Nihon Kohden Corporation (OTCMKTS:NHNKY – Get Free Report) was the target of a large decline in short interest during the month of May. As of May 15th, there was short interest totaling 3,556 shares, a decline of 83.6% from the April 30th total of 21,619 shares. Currently, 0.0% of the company’s stock are sold short. Based on an average daily trading volume, of 39,773 shares, the days-to-cover ratio is currently 0.1 days.
Nihon Kohden Price Performance
Shares of NHNKY stock traded down $0.16 during trading on Friday, reaching $9.00. The company had a trading volume of 7,835 shares, compared to its average volume of 14,444. The firm’s 50 day simple moving average is $9.38 and its two-hundred day simple moving average is $10.33. Nihon Kohden has a one year low of $8.71 and a one year high of $14.21. The company has a market capitalization of $1.54 billion, a PE ratio of 15.25 and a beta of 0.41.
Nihon Kohden (OTCMKTS:NHNKY – Get Free Report) last issued its quarterly earnings data on Thursday, May 14th. The company reported $0.34 earnings per share for the quarter, beating analysts’ consensus estimates of $0.24 by $0.10. Nihon Kohden had a return on equity of 9.48% and a net margin of 6.08%.The business had revenue of $453.10 million for the quarter, compared to the consensus estimate of $414.40 million. Analysts forecast that Nihon Kohden will post 0.61 earnings per share for the current year.
Wall Street Analyst Weigh In
Get Our Latest Stock Report on NHNKY
Nihon Kohden Company Profile
Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan’s earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.
The company’s core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.
See Also
- Five stocks we like better than Nihon Kohden
- These 3 Software Stocks Are Buying Back Shares Hand Over Fist
- Gap Inc. Cuts Sales Outlook After Q1 Miss, Shares Drop 17%
- MongoDB’s AI Advantage Is Starting to Show Up in Results
- MarketBeat Week in Review – 05/25 – 05/29
Receive News & Ratings for Nihon Kohden Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nihon Kohden and related companies with MarketBeat.com's FREE daily email newsletter.
